1,2-dimethylhydrazine multiple interactions ISO RGD:1332294 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP1LC3A mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MAP1LC3A mRNA CTD PMID:25380136 17alpha-ethynylestradiol affects expression ISO RGD:1332294 6480464 Ethinyl Estradiol affects the expression of MAP1LC3A mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1332294 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP1LC3A mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of MAP1LC3A mRNA CTD PMID:17351261 2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene increases expression ISO RGD:1332294 6480464 2 more ... CTD PMID:32721735 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1332294 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1332294 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP1LC3A mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP1LC3A mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1LC3A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332294 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1LC3A mRNA CTD PMID:21570461 , PMID:24680724 2-deoxy-D-glucose multiple interactions ISO RGD:1347480 6480464 Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of MAP1LC3A mRNA] CTD PMID:26079942 2-hydroxypropanoic acid decreases expression ISO RGD:1347480 6480464 Lactic Acid results in decreased expression of MAP1LC3A mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1332294 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of MAP1LC3A mRNA CTD PMID:20188158 3-methyladenine multiple interactions ISO RGD:1332294 6480464 3-methyladenine inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3A protein modified form] CTD PMID:20008137 3-methyladenine affects metabolic processing ISO RGD:1347480 6480464 3-methyladenine affects the metabolism of MAP1LC3A protein CTD PMID:21742779 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of MAP1LC3A mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAP1LC3A mRNA CTD PMID:36041667 4-aminopyridine increases expression EXP 6480464 4-Aminopyridine results in increased expression of MAP1LC3A mRNA CTD PMID:24378259 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of MAP1LC3A mRNA CTD PMID:30228064 5-aza-2'-deoxycytidine affects expression ISO RGD:1347480 6480464 Decitabine affects the expression of MAP1LC3A mRNA CTD PMID:23300844 5-chloro-7-iodoquinolin-8-ol increases expression ISO RGD:1347480 6480464 Clioquinol results in increased expression of MAP1LC3A protein CTD PMID:36396104 abamectin increases expression EXP 6480464 abamectin results in increased expression of MAP1LC3A mRNA CTD PMID:34748272 abamectin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3A mRNA] CTD PMID:34748272 acadesine multiple interactions ISO RGD:1347480 6480464 acadesine promotes the reaction [Capsaicin affects the localization of MAP1LC3A protein] CTD PMID:36044967 acetamide increases expression EXP 6480464 acetamide results in increased expression of MAP1LC3A mRNA CTD PMID:31881176 acrylonitrile increases expression ISO RGD:1332294 6480464 Acrylonitrile results in increased expression of MAP1LC3A mRNA CTD PMID:35429547 alpha,alpha-trehalose increases expression ISO RGD:1332294 6480464 Trehalose results in increased expression of MAP1LC3A mRNA CTD PMID:23851366 amitrole multiple interactions ISO RGD:1347480 6480464 Amitrole inhibits the reaction [dihydrocapsaicin results in increased expression of MAP1LC3A protein] CTD PMID:18818525 ammonium chloride decreases degradation ISO RGD:1347480 6480464 Ammonium Chloride results in decreased degradation of MAP1LC3A protein alternative form CTD PMID:21742779 antirheumatic drug increases expression ISO RGD:1347480 6480464 Antirheumatic Agents results in increased expression of MAP1LC3A mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:1347480 6480464 aristolochic acid I results in increased expression of MAP1LC3A mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1347480 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased lipidation of MAP1LC3A protein CTD PMID:31781319 arsenous acid increases expression ISO RGD:1347480 6480464 Arsenic Trioxide results in increased expression of MAP1LC3A protein CTD PMID:20200477 arsenous acid increases expression ISO RGD:1332294 6480464 Arsenic Trioxide results in increased expression of MAP1LC3A mRNA CTD PMID:30032600 more ... bafilomycin A1 multiple interactions ISO RGD:1332294 6480464 bafilomycin A1 promotes the reaction [Uranium results in increased expression of MAP1LC3A protein] CTD PMID:31120128 bafilomycin A1 increases expression ISO RGD:1347480 6480464 bafilomycin A1 results in increased expression of MAP1LC3A protein modified form CTD PMID:30871063 benzo[a]pyrene increases methylation ISO RGD:1347480 6480464 Benzo(a)pyrene results in increased methylation of MAP1LC3A 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1347480 6480464 Benzo(a)pyrene results in increased expression of MAP1LC3A mRNA CTD PMID:34332006 bis(2-chloroethyl) sulfide increases expression ISO RGD:1347480 6480464 Mustard Gas results in increased expression of MAP1LC3A mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1332294 6480464 Diethylhexyl Phthalate results in increased expression of MAP1LC3A mRNA CTD PMID:21318169 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP1LC3A mRNA CTD PMID:25181051 bisphenol A affects localization ISO RGD:1332294 6480464 bisphenol A affects the localization of MAP1LC3A protein CTD PMID:35357751 bisphenol A decreases expression ISO RGD:1332294 6480464 bisphenol A results in decreased expression of MAP1LC3A mRNA CTD PMID:35598803 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAP1LC3A mRNA CTD PMID:36041667 bisphenol A increases expression ISO RGD:1332294 6480464 bisphenol A results in increased expression of MAP1LC3A mRNA CTD PMID:34281243 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAP1LC3A mRNA CTD PMID:30816183 , PMID:33296240 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP1LC3A mRNA CTD PMID:27539358 more ... bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of MAP1LC3A mRNA CTD PMID:36041667 butanal increases expression ISO RGD:1347480 6480464 butyraldehyde results in increased expression of MAP1LC3A mRNA CTD PMID:26079696 cadmium dichloride multiple interactions ISO RGD:1332294 6480464 Chloroquine affects the reaction [Cadmium Chloride results in increased expression of MAP1LC3A protein] CTD PMID:35843418 cadmium dichloride affects expression ISO RGD:1332294 6480464 Cadmium Chloride affects the expression of MAP1LC3A protein CTD PMID:35843418 cadmium dichloride increases expression ISO RGD:1332294 6480464 Cadmium Chloride results in increased expression of MAP1LC3A protein CTD PMID:35843418 cadmium sulfide decreases expression ISO RGD:1347480 6480464 cadmium sulfide results in decreased expression of MAP1LC3A mRNA CTD PMID:27866839 calyculin a increases expression ISO RGD:1332294 6480464 calyculin A results in increased expression of MAP1LC3A mRNA CTD PMID:25270620 capsaicin affects localization ISO RGD:1347480 6480464 Capsaicin affects the localization of MAP1LC3A protein CTD PMID:36044967 capsaicin multiple interactions ISO RGD:1347480 6480464 acadesine promotes the reaction [Capsaicin affects the localization of MAP1LC3A protein], dorsomorphin inhibits the reaction [Capsaicin affects the localization of MAP1LC3A protein] CTD PMID:36044967 carbamazepine multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in increased expression of MAP1LC3A protein CTD PMID:35786680 carbon nanotube increases expression ISO RGD:1347480 6480464 Nanotubes, Carbon results in increased expression of MAP1LC3A mRNA CTD PMID:29348435 CGP 52608 multiple interactions ISO RGD:1347480 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP1LC3A gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO RGD:1332294 6480464 Chir 99021 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein] CTD PMID:30165626 chloroquine increases expression ISO RGD:1347480 6480464 Chloroquine results in increased expression of MAP1LC3A protein, Chloroquine results in increased expression of MAP1LC3A protein modified form CTD PMID:30280407 , PMID:30871063 chloroquine multiple interactions ISO RGD:1332294 6480464 Chloroquine affects the reaction [Cadmium Chloride results in increased expression of MAP1LC3A protein] CTD PMID:35843418 chloroquine multiple interactions ISO RGD:1347480 6480464 Chloroquine inhibits the reaction [hydroquinone results in increased degradation of MAP1LC3A protein] CTD PMID:35302183 chlorpyrifos increases expression ISO RGD:1332294 6480464 Chlorpyrifos results in increased expression of MAP1LC3A mRNA CTD PMID:27737797 chlorpyrifos multiple interactions ISO RGD:1332294 6480464 [Paraquat co-treated with Chlorpyrifos] results in decreased expression of MAP1LC3A protein CTD PMID:26884967 cisplatin affects expression ISO RGD:1347480 6480464 Cisplatin affects the expression of MAP1LC3A mRNA CTD PMID:23300844 cisplatin multiple interactions ISO RGD:1347480 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of MAP1LC3A mRNA CTD PMID:30871063 cisplatin decreases expression ISO RGD:1347480 6480464 Cisplatin results in decreased expression of MAP1LC3A mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:1332294 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MAP1LC3A mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MAP1LC3A mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:1332294 6480464 Clofibrate results in decreased expression of MAP1LC3A mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAP1LC3A mRNA CTD PMID:17602206 cocaine affects expression EXP 6480464 Cocaine affects the expression of MAP1LC3A mRNA CTD PMID:20187946 copper atom multiple interactions ISO RGD:1332294 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3A protein CTD PMID:31491480 copper(0) multiple interactions ISO RGD:1332294 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3A protein CTD PMID:31491480 copper(II) sulfate increases expression ISO RGD:1347480 6480464 Copper Sulfate results in increased expression of MAP1LC3A mRNA CTD PMID:19549813 copper(II) sulfate multiple interactions ISO RGD:1332294 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3A protein CTD PMID:31491480 cordycepin increases expression ISO RGD:1347480 6480464 cordycepin results in increased expression of MAP1LC3A mRNA CTD PMID:28987792 cypermethrin increases expression ISO RGD:1347480 6480464 cypermethrin results in increased expression of MAP1LC3A mRNA CTD PMID:27704156 dactolisib increases metabolic processing ISO RGD:1347480 6480464 dactolisib results in increased metabolism of MAP1LC3A protein CTD PMID:23651616 dactolisib affects localization ISO RGD:1347480 6480464 dactolisib affects the localization of MAP1LC3A protein CTD PMID:23651616 DDE affects expression ISO RGD:1332294 6480464 Dichlorodiphenyl Dichloroethylene affects the expression of MAP1LC3A mRNA CTD PMID:32721735 DDE increases expression ISO RGD:1332294 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of MAP1LC3A protein CTD PMID:32721735 desferrioxamine B multiple interactions ISO RGD:1347480 6480464 Deferoxamine inhibits the reaction [Hydrogen Peroxide affects the localization of MAP1LC3A protein] CTD PMID:21742779 diarsenic trioxide increases expression ISO RGD:1347480 6480464 Arsenic Trioxide results in increased expression of MAP1LC3A protein CTD PMID:20200477 diarsenic trioxide increases expression ISO RGD:1332294 6480464 Arsenic Trioxide results in increased expression of MAP1LC3A mRNA CTD PMID:30032600 more ... dihydrocapsaicin multiple interactions ISO RGD:1347480 6480464 Amitrole inhibits the reaction [dihydrocapsaicin results in increased expression of MAP1LC3A protein] more ... CTD PMID:18818525 dihydrocapsaicin increases expression ISO RGD:1347480 6480464 dihydrocapsaicin results in increased expression of MAP1LC3A protein CTD PMID:18818525 dorsomorphin multiple interactions ISO RGD:1347480 6480464 dorsomorphin inhibits the reaction [Capsaicin affects the localization of MAP1LC3A protein], dorsomorphin inhibits the reaction [sulphoraphene results in increased expression of MAP1LC3A protein] CTD PMID:29247643 , PMID:36044967 doxorubicin affects expression ISO RGD:1347480 6480464 Doxorubicin affects the expression of MAP1LC3A mRNA CTD PMID:26969377 doxorubicin multiple interactions EXP 6480464 HDAC6 protein affects the reaction [Doxorubicin affects the localization of MAP1LC3A protein], NLRP3 protein affects the reaction [HDAC6 protein affects the reaction [Doxorubicin affects the localization of MAP1LC3A protein]] CTD PMID:35764897 doxorubicin affects localization EXP 6480464 Doxorubicin affects the localization of MAP1LC3A protein CTD PMID:35764897 doxorubicin multiple interactions ISO RGD:1347480 6480464 [Doxorubicin co-treated with resveratrol] results in decreased expression of MAP1LC3A mRNA CTD PMID:26969377 epoxiconazole increases expression ISO RGD:1332294 6480464 epoxiconazole results in increased expression of MAP1LC3A mRNA CTD PMID:35436446 ethanol affects splicing ISO RGD:1332294 6480464 Ethanol affects the splicing of MAP1LC3A mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1332294 6480464 Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein] CTD PMID:36535314 ethanol increases expression ISO RGD:1332294 6480464 Ethanol results in increased expression of MAP1LC3A mRNA, Ethanol results in increased expression of MAP1LC3A protein CTD PMID:30319688 , PMID:36535314 fenofibrate increases expression ISO RGD:1332294 6480464 Fenofibrate results in increased expression of MAP1LC3A mRNA CTD PMID:21318169 fenofibrate multiple interactions ISO RGD:1332294 6480464 [PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of MAP1LC3A mRNA CTD PMID:21318169 fenthion increases expression ISO RGD:1332294 6480464 Fenthion results in increased expression of MAP1LC3A mRNA CTD PMID:34813904 ferric oxide increases expression ISO RGD:1332294 6480464 ferric oxide analog results in increased expression of MAP1LC3A protein CTD PMID:25086211 folic acid multiple interactions ISO RGD:1332294 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP1LC3A mRNA CTD PMID:22206623 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MAP1LC3A mRNA CTD PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAP1LC3A mRNA CTD PMID:33387578 glyphosate increases expression ISO RGD:1332294 6480464 glyphosate results in increased expression of MAP1LC3A mRNA CTD PMID:31352102 hesperidin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3A mRNA] more ... CTD PMID:34748272 more ... hydrogen peroxide multiple interactions ISO RGD:1347480 6480464 Deferoxamine inhibits the reaction [Hydrogen Peroxide affects the localization of MAP1LC3A protein] CTD PMID:21742779 hydrogen peroxide increases metabolic processing ISO RGD:1347480 6480464 Hydrogen Peroxide results in increased metabolism of MAP1LC3A protein CTD PMID:21742779 hydrogen peroxide affects localization ISO RGD:1347480 6480464 Hydrogen Peroxide affects the localization of MAP1LC3A protein CTD PMID:21742779 hydroquinone multiple interactions ISO RGD:1347480 6480464 Chloroquine inhibits the reaction [hydroquinone results in increased degradation of MAP1LC3A protein], hydroquinone affects the localization of and results in increased degradation of MAP1LC3A protein CTD PMID:35302183 ivermectin decreases expression ISO RGD:1347480 6480464 Ivermectin results in decreased expression of MAP1LC3A protein CTD PMID:32959892 lead(0) affects expression ISO RGD:1347480 6480464 Lead affects the expression of MAP1LC3A mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1347480 6480464 Lead affects the expression of MAP1LC3A mRNA CTD PMID:28903495 LY294002 multiple interactions ISO RGD:1332294 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA]], 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA] CTD PMID:35568058 melatonin multiple interactions ISO RGD:1332294 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA]], Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA] CTD PMID:35568058 methidathion increases expression ISO RGD:1332294 6480464 methidathion results in increased expression of MAP1LC3A mRNA CTD PMID:34813904 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1332294 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A mRNA, 1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein CTD PMID:30165626 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 Imatinib Mesylate inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein] CTD PMID:30165626 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein CTD PMID:30165626 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:1332294 6480464 Chir 99021 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein], Imatinib Mesylate inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein] CTD PMID:30165626 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAP1LC3A mRNA CTD PMID:17602206 nickel atom decreases expression ISO RGD:1347480 6480464 Nickel results in decreased expression of MAP1LC3A mRNA CTD PMID:24768652 , PMID:25583101 nickel atom multiple interactions ISO RGD:1332294 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA]] more ... CTD PMID:35568058 nickel dichloride multiple interactions ISO RGD:1332294 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA]] more ... CTD PMID:35568058 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of MAP1LC3A mRNA CTD PMID:27832966 okadaic acid increases expression ISO RGD:1332294 6480464 Okadaic Acid results in increased expression of MAP1LC3A mRNA CTD PMID:25270620 paclitaxel multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MAP1LC3A mRNA] CTD PMID:35921949 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of MAP1LC3A mRNA CTD PMID:35921949 paracetamol multiple interactions ISO RGD:1332294 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MAP1LC3A mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MAP1LC3A mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAP1LC3A mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1347480 6480464 Acetaminophen results in increased expression of MAP1LC3A mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:1332294 6480464 Acetaminophen affects the expression of MAP1LC3A mRNA CTD PMID:17562736 paraquat increases expression ISO RGD:1332294 6480464 Paraquat results in increased expression of MAP1LC3A protein CTD PMID:22982048 paraquat multiple interactions ISO RGD:1332294 6480464 [Paraquat co-treated with Chlorpyrifos] results in decreased expression of MAP1LC3A protein CTD PMID:26884967 paraquat multiple interactions ISO RGD:1347480 6480464 ATG5 protein affects the reaction [Paraquat results in increased expression of MAP1LC3A protein], ATP6V0A1 protein affects the reaction [Paraquat results in increased expression of MAP1LC3A protein] CTD PMID:22982048 paraquat increases expression ISO RGD:1347480 6480464 Paraquat results in increased expression of MAP1LC3A protein CTD PMID:22982048 perfluorooctanoic acid multiple interactions ISO RGD:1332294 6480464 PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of MAP1LC3A mRNA] CTD PMID:21318169 perfluorooctanoic acid increases expression ISO RGD:1347480 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3A protein modified form CTD PMID:26879310 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3A mRNA CTD PMID:19162173 , PMID:21318169 perfluorooctanoic acid increases expression ISO RGD:1332294 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3A mRNA, perfluorooctanoic acid results in increased expression of MAP1LC3A protein modified form CTD PMID:21318169 , PMID:26879310 perfluoroundecanoic acid decreases expression EXP 6480464 perfluoroundecanoic acid results in decreased expression of MAP1LC3A protein CTD PMID:33549592 picoxystrobin decreases expression ISO RGD:1347480 6480464 picoxystrobin results in decreased expression of MAP1LC3A mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1332294 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of MAP1LC3A mRNA] CTD PMID:21318169 pirinixic acid increases expression ISO RGD:1332294 6480464 pirinixic acid results in increased expression of MAP1LC3A mRNA CTD PMID:18301758 more ... platycodin D multiple interactions ISO RGD:1347480 6480464 U 0126 inhibits the reaction [platycodin D results in increased expression of MAP1LC3A protein] CTD PMID:25592318 platycodin D increases expression ISO RGD:1347480 6480464 platycodin D results in increased expression of MAP1LC3A protein CTD PMID:25592318 ponatinib increases lipidation ISO RGD:1347480 6480464 ponatinib results in increased lipidation of MAP1LC3A protein CTD PMID:29341879 rac-lactic acid decreases expression ISO RGD:1347480 6480464 Lactic Acid results in decreased expression of MAP1LC3A mRNA CTD PMID:30851411 resorcinol increases lipidation ISO RGD:1347480 6480464 resorcinol analog results in increased lipidation of MAP1LC3A protein CTD PMID:24910342 resveratrol multiple interactions ISO RGD:1347480 6480464 [Doxorubicin co-treated with resveratrol] results in decreased expression of MAP1LC3A mRNA CTD PMID:26969377 resveratrol decreases expression ISO RGD:1347480 6480464 resveratrol results in decreased expression of MAP1LC3A mRNA CTD PMID:26969377 rotenone decreases expression ISO RGD:1332294 6480464 Rotenone results in decreased expression of MAP1LC3A mRNA CTD PMID:23186747 sirolimus multiple interactions ISO RGD:1347480 6480464 [Sirolimus inhibits the reaction [MTOR protein binds to RPTOR protein]] which results in increased expression of MAP1LC3A protein alternative form CTD PMID:21742779 sodium arsenite multiple interactions ISO RGD:1332294 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3A protein modified form] more ... CTD PMID:20008137 , PMID:30097599 sodium arsenite multiple interactions ISO RGD:1347480 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased lipidation of MAP1LC3A protein CTD PMID:31781319 sodium arsenite increases expression ISO RGD:1332294 6480464 sodium arsenite results in increased expression of MAP1LC3A mRNA, sodium arsenite results in increased expression of MAP1LC3A protein modified form CTD PMID:20008137 , PMID:30097599 sodium fluoride increases expression ISO RGD:1332294 6480464 Sodium Fluoride results in increased expression of MAP1LC3A mRNA CTD PMID:24296261 sodium fluoride multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of MAP1LC3A protein] CTD PMID:35413380 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of MAP1LC3A mRNA, Sodium Fluoride results in increased expression of MAP1LC3A protein CTD PMID:24296261 , PMID:35413380 Soman increases expression EXP 6480464 Soman results in increased expression of MAP1LC3A mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in increased expression of MAP1LC3A protein CTD PMID:35786680 sunitinib decreases expression ISO RGD:1347480 6480464 Sunitinib results in decreased expression of MAP1LC3A mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1332294 6480464 Tamoxifen affects the expression of MAP1LC3A mRNA CTD PMID:17555576 temozolomide decreases expression ISO RGD:1347480 6480464 Temozolomide results in decreased expression of MAP1LC3A mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:1332294 6480464 Testosterone results in increased expression of MAP1LC3A mRNA CTD PMID:20403060 tetrachloromethane affects expression ISO RGD:1332294 6480464 Carbon Tetrachloride affects the expression of MAP1LC3A mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1332294 6480464 Carbon Tetrachloride results in increased expression of MAP1LC3A mRNA CTD PMID:31919559 thymol increases expression ISO RGD:1332294 6480464 Thymol results in increased expression of MAP1LC3A protein CTD PMID:36535314 thymol multiple interactions ISO RGD:1332294 6480464 Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein] CTD PMID:36535314 thymol sulfate(1-) increases expression ISO RGD:1332294 6480464 Thymol results in increased expression of MAP1LC3A protein CTD PMID:36535314 thymol sulfate(1-) multiple interactions ISO RGD:1332294 6480464 Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein] CTD PMID:36535314 thymoquinone increases lipidation ISO RGD:1347480 6480464 thymoquinone results in increased lipidation of MAP1LC3A protein CTD PMID:31298468 titanium dioxide decreases expression ISO RGD:1332294 6480464 titanium dioxide results in decreased expression of MAP1LC3A mRNA CTD PMID:23557971 toluene decreases expression EXP 6480464 Toluene results in decreased expression of MAP1LC3A mRNA CTD PMID:22967744 trovafloxacin multiple interactions ISO RGD:1347480 6480464 TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3A mRNA] CTD PMID:33609687 trovafloxacin increases expression ISO RGD:1347480 6480464 trovafloxacin results in increased expression of MAP1LC3A mRNA CTD PMID:33609687 uranium atom multiple interactions ISO RGD:1332294 6480464 bafilomycin A1 promotes the reaction [Uranium results in increased expression of MAP1LC3A protein] CTD PMID:31120128 uranium atom increases expression ISO RGD:1332294 6480464 Uranium results in increased expression of MAP1LC3A protein CTD PMID:31120128 valproic acid affects expression ISO RGD:1332294 6480464 Valproic Acid affects the expression of MAP1LC3A mRNA CTD PMID:17963808 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of MAP1LC3A mRNA CTD PMID:21318169 valproic acid increases expression ISO RGD:1332294 6480464 Valproic Acid results in increased expression of MAP1LC3A mRNA CTD PMID:20546886 , PMID:21427059 valproic acid affects expression ISO RGD:1347480 6480464 Valproic Acid affects the expression of MAP1LC3A mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:1347480 6480464 Valproic Acid results in increased methylation of MAP1LC3A gene CTD PMID:29154799 vemurafenib multiple interactions ISO RGD:1347480 6480464 [Vemurafenib co-treated with 3, 5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one] affects the localization of MAP1LC3A protein CTD PMID:35648318 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MAP1LC3A mRNA CTD PMID:23034163 XL147 multiple interactions ISO RGD:1332294 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of MAP1LC3A mRNA] CTD PMID:29891994 zearalenone increases expression ISO RGD:1332294 6480464 Zearalenone results in increased expression of MAP1LC3A mRNA CTD PMID:34537261 zerumbone decreases expression ISO RGD:1347480 6480464 zerumbone results in decreased expression of MAP1LC3A mRNA CTD PMID:36122806
